Literature DB >> 29229874

Induction of morphological and functional differentiation of human neuroblastoma cells by miR-124.

Samaneh Sharif1, Mohammad Hossein Ghahremani, Masoud Soleimani.   

Abstract

Neuroblastoma is the most common extracranial solid tumour in children, and differentiation is considered its most appropriate therapy. In this work, we studied effects of miR-124 overexpression on differentiation in M17 cell line as a model of neuroblastoma cancer. Influence of miR-124 overexpression on differentiation in M17 cells was studied. M17 cells were infected with lentivirus that contained miR-124 precursor sequence and followed for 2 weeks to differentiate. Ectopic expression of miR-124 in M17 cells changed the shape of spherical undifferentiated cells to cells with extended neurites that formed neuronal networks. Overexpression of MiR-124 respectively increased the expression level of markers of β-Tubulin III, MAP2, SYN, NF-M and Nestin by 16-, 5-, 4-, 2.3- and 2-folds at the messenger RNA level. MiR-124 overexpression also increased the protein levels of β-Tubulin III and MAP2. Moreover, exogenous expression of miR-124 significantly increased the intracellular calcium in differentiated M17 cells. Since miR-124 is naturally expressed in neuronal cells and is downregulated in neuroblastoma cancer cells, differentiation with this type of microRNA can be a novel treatment for neuroblastoma cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29229874     DOI: 10.1007/s12038-017-9714-5

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  31 in total

1.  MicroRNA-144-3p inhibits proliferation and induces apoptosis of human salivary adenoid carcinoma cells via targeting of mTOR.

Authors:  Fangyi Huo; Chen Zhang; Hong He; Yunlong Wang
Journal:  Biotechnol Lett       Date:  2015-12-19       Impact factor: 2.461

2.  Nestin expression in ganglioglioma.

Authors:  Neil Duggal; Robert R Hammond
Journal:  Exp Neurol       Date:  2002-03       Impact factor: 5.330

3.  Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.

Authors:  Katherine K Matthay; C Patrick Reynolds; Robert C Seeger; Hiroyuki Shimada; E Stanton Adkins; Daphne Haas-Kogan; Robert B Gerbing; Wendy B London; Judith G Villablanca
Journal:  J Clin Oncol       Date:  2009-01-26       Impact factor: 44.544

Review 4.  The roles of microRNAs in neuroblastoma.

Authors:  Hong Mei; Zhen-Yu Lin; Qiang-Song Tong
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

5.  The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation.

Authors:  Riccardo Taulli; Francesca Bersani; Valentina Foglizzo; Alessandra Linari; Elisa Vigna; Marc Ladanyi; Thomas Tuschl; Carola Ponzetto
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

6.  miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1.

Authors:  Kay Ka Wai Li; Jesse Chung-sean Pang; Arthur Ka-keung Ching; Chun Kwok Wong; Xiangyin Kong; Yin Wang; Liangfu Zhou; Zhongping Chen; Ho-keung Ng
Journal:  Hum Pathol       Date:  2009-05-07       Impact factor: 3.466

7.  Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma.

Authors:  Jessica Pierson; Bruce Hostager; Rong Fan; Rajeev Vibhakar
Journal:  J Neurooncol       Date:  2008-07-08       Impact factor: 4.130

Review 8.  Neuroblastoma: biology, prognosis, and treatment.

Authors:  Julie R Park; Angelika Eggert; Huib Caron
Journal:  Pediatr Clin North Am       Date:  2008-02       Impact factor: 3.278

9.  CNF1 improves astrocytic ability to support neuronal growth and differentiation in vitro.

Authors:  Fiorella Malchiodi-Albedi; Silvia Paradisi; Michela Di Nottia; Daiana Simone; Sara Travaglione; Loredana Falzano; Marco Guidotti; Claudio Frank; Alessandro Cutarelli; Alessia Fabbri; Carla Fiorentini
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

10.  MicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicity.

Authors:  Leleesha Samaraweera; Kathryn B Grandinetti; Ruojun Huang; Barbara A Spengler; Robert A Ross
Journal:  BMC Cancer       Date:  2014-05-02       Impact factor: 4.430

View more
  5 in total

Review 1.  Emerging therapeutic targets for neuroblastoma.

Authors:  Natarajan Aravindan; Terence Herman; Sheeja Aravindan
Journal:  Expert Opin Ther Targets       Date:  2020-10-06       Impact factor: 6.902

2.  Differentiation Induction and Proliferation Inhibition by A Cell-Free Approach for Delivery of Exogenous miRNAs to Neuroblastoma Cells Using Mesenchymal Stem Cells.

Authors:  Mohammad Hossein Ghahremani; Masoud Soleimani; Samaneh Sharif
Journal:  Cell J       Date:  2020-04-27       Impact factor: 2.479

Review 3.  Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma.

Authors:  Omidvar Rezaei; Kasra Honarmand Tamizkar; Mohammadreza Hajiesmaeili; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

4.  SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p/PLK4 pathway in neuroblastoma cells.

Authors:  Zhaoying Xu; Yongfa Sun; Danfeng Wang; Huifang Sun; Xiaojun Liu
Journal:  Cancer Cell Int       Date:  2020-06-12       Impact factor: 5.722

5.  Role of miR-124 in the regulation of retinoic acid-induced Neuro-2A cell differentiation.

Authors:  Qun You; Qiang Gong; Yu-Qiao Han; Rou Pi; Yi-Jie Du; Su-Zhen Dong
Journal:  Neural Regen Res       Date:  2020-06       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.